BlackRock
ORGO icon

BlackRock’s Organogenesis Holdings ORGO Stock Holding History

BlackRock’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6M Buy
7,249,528
+2,349,777
+48% +$5.74M ﹤0.01% 3344
2026
Q1 		$11.6M Buy
4,899,751
+138,657
+3% +$480K ﹤0.01% 3397
2025
Q4 		$24.7M Buy
4,761,094
+176,157
+4% +$854K ﹤0.01% 2976
2025
Q3 		$19.3M Sell
4,584,937
-148,992
-3% -$693K ﹤0.01% 3101
2025
Q2 		$17.3M Sell
4,733,929
-422,474
-8% -$1.57M ﹤0.01% 3117
2025
Q1 		$22.3M Sell
5,156,403
-119,618
-2% -$483K ﹤0.01% 2867
2024
Q4 		$16.9M Sell
5,276,021
-53,391
-1% -$179K ﹤0.01% 3149
2024
Q3 		$15.2M Buy
5,329,412
+242,266
+5% +$679K ﹤0.01% 3196
2024
Q2 		$14.2M Buy
5,087,146
+112,845
+2% +$303K ﹤0.01% 3171
2024
Q1 		$14.1M Sell
4,974,301
-223,886
-4% -$761K ﹤0.01% 3173
2023
Q4 		$21.3M Buy
5,198,187
+253,037
+5% +$709K ﹤0.01% 2989
2023
Q3 		$15.7M Buy
4,945,150
+99,857
+2% +$317K ﹤0.01% 3076
2023
Q2 		$16.1M Buy
4,845,293
+356,680
+8% +$1.05M ﹤0.01% 3170
2023
Q1 		$9.56M Sell
4,488,613
-6,614,577
-60% -$16.3M ﹤0.01% 3341
2022
Q4 		$29.9M Buy
11,103,190
+566,429
+5% +$1.65M ﹤0.01% 2806
2022
Q3 		$34.1M Buy
10,536,761
+861,588
+9% +$3.89M ﹤0.01% 2721
2022
Q2 		$47.2M Buy
9,675,173
+22,985
+0.2% +$141K ﹤0.01% 2539
2022
Q1 		$73.6M Buy
9,652,188
+1,412,356
+17% +$10.9M ﹤0.01% 2335
2021
Q4 		$76.1M Buy
8,239,832
+165,724
+2% +$1.76M ﹤0.01% 2386
2021
Q3 		$115M Buy
8,074,108
+1,052,935
+15% +$16.4M ﹤0.01% 2122
2021
Q2 		$117M Buy
7,021,173
+4,730,593
+207% +$88.2M ﹤0.01% 2161
2021
Q1 		$41.7M Buy
2,290,580
+1,026,183
+81% +$13.9M ﹤0.01% 2740
2020
Q4 		$9.52M Buy
1,264,397
+206,412
+20% +$980K ﹤0.01% 3385
2020
Q3 		$4.06M Sell
1,057,985
-4,398
-0.4% -$17.4K ﹤0.01% 3650
2020
Q2 		$4.08M Buy
1,062,383
+411,298
+63% +$1.48M ﹤0.01% 3601
2020
Q1 		$2.1M Buy
651,085
+23,052
+4% +$98.7K ﹤0.01% 3641
2019
Q4 		$3.02M Buy
628,033
+35,645
+6% +$226K ﹤0.01% 3653
2019
Q3 		$3.89M Buy
592,388
+37,550
+7% +$209K ﹤0.01% 3552
2019
Q2 		$4.22M Buy
554,838
+486,870
+716% +$3.58M ﹤0.01% 3574
2019
Q1 		$510K Buy
+67,968
New +$1.36M ﹤0.01% 4097

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BlackRock's ORGO Position: Q2 2026 in Review

BlackRock increased its Organogenesis Holdings (ORGO) stake by 48% in Q2 2026, buying an estimated $5.74M and bringing the position to 7,249,528 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3344.

BlackRock first reported a position in ORGO in Q1 2019 and has held it in 30 quarters since. The position peaked at $117M in Q2 2021. 135 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • BlackRock held 7,249,528 shares of Organogenesis Holdings worth $17.6M as of Q2 2026.
  • BlackRock bought 2,349,777 Organogenesis Holdings shares in Q2 2026, an estimated $5.74M.
  • Organogenesis Holdings made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3344 holding.
  • BlackRock first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 30 quarters since.
  • BlackRock's Organogenesis Holdings position peaked at $117M in Q2 2021.
  • 135 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.